• Home
• About us
• GSK at a glance

GSK at a glance

• Our mission is to improve the quality of human life by enabling people to do more, feel better and live longer
• We are a research-based pharmaceutical company
• We are committed to tackling the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria
• Our business employs around 99,000 people in over 100 countries
• We make almost four billion packs of medicines and healthcare products every year
• Over 15,000 people work in our research teams to discover new medicines
• We screen about 65 million compounds every year in our search for new medicines
• We supply one quarter of the world's vaccines and by the end of February 2009 we had more than 20 vaccines in clinical development
• January 2008 marked the tenth anniversary of our programme to help eliminate lymphatic filariasis (elephantiasis). During those ten years we donated 750 million albendazole tablets, reaching over 130 million people
• In 2007 we marked 15 years of our Positive Action programme that helps communities living with HIV/AIDS
• In the developing world, we provide certain medicines at preferential prices ensuring that the poorest can still benefit from our treatments and vaccines
• In 2007, our total community investment was valued at £282 million, equivalent to 3.8 per cent of Group total profit before tax
• Many of our consumer brands are household names: Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums, Zovirax.